Danish CNS specialist Lundbeck (LUND: CO) today released first-quarter 2025 financials, along with a raised guidance for the ...

Belgian biotech Galapagos (Euronext: GLPG) is pausing its high-profile plan to break into two separate businesses, just five ...

Representatives of Russian patent unions have sent an appeal to the Russian Scientific Center for Expertise of Medical ...

Finnish biotech Tilt Biotherapeutics has raised $26 million (22.6 million euros) in a series B round to move its lead cancer ...

A clinical-stage biotech company developing a new class of small molecule therapeutics that target nicotinamide ...

Compugen, an Israeli cancer immunotherapy company that calls itself a pioneer in computational target discovery, has ...

The Russian authorities are preparing for a further reduction of the share of imported drugs in the domestic public ...

Privately-held Remedy Plan Therapeutics, a US pharma company developing novel, hyperbolic NAMPT inhibitors, has raised more ...

Belgian clinical-stage biotech iTeos Therapeutics (Nasdaq: ITOS) saw its shar leap18.6% to $8.20 today, despite posting ...

Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) ...

India has declined the UK's request to include a 'data exclusivity' clause in the proposed Free Trade Agreement (FTA), as ...

Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) has appointed Maria Törnsén as chief operating officer and president ...